Why do metastases often only appear after the original tumor has been surgically removed? Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim Medical Faculty of Heidelberg ...
Oct 26, 2022
0
40
A multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive breast cancer in the U.S.—showed that, despite its prevalence, ILC is detected later ...
Oct 14, 2022
0
41
Scientists at the UK's National Physical Laboratory (NPL) have demonstrated the first in-person measurements of breast tissue using an innovative new detection technique, which has the potential to significantly improve breast ...
Sep 21, 2022
0
7
Tumors have significant differences depending on the person affected, even if they are the same cancer, such as breast cancer. Therefore, precision oncology targets specific genetic characteristics of a tumor and incorporates ...
Sep 1, 2022
0
4
Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple ...
Aug 29, 2022
0
37
A team led by scientists Dr. Maximilian Kückelhaus and Prof. Tobias Hirsch from the Centre for Musculoskeletal Medicine at the University of Münster has carried out the first completely robot-supported microsurgical operations ...
Aug 19, 2022
0
89
An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy ...
Aug 9, 2022
0
945
Tumor heterogeneity refers to the presence of a variety of distinct cell types within a tumor. High tumor heterogeneity is thought to contribute to breast cancer progression and metastasis, or spreading to other parts of ...
Aug 4, 2022
0
56
University of Toronto researchers have designed a new way to grow cells in a lab that enables them to better emulate cancerous tumors. The platform—based on a type of material known as a hydrogel, a soft jelly-like substance—opens ...
Aug 1, 2022
0
69
Breast cancers with HER2 mutations respond to the drug neratinib, but the responses are variable and often not durable. Looking to better understand the underlying cause of this variation, a team led by researchers at Baylor ...
Jun 23, 2022
0
6
